Zydus Cyanocobalamin Injection Recall: Glass Particulate Matter Hazard
Zydus Pharmaceuticals recalls cyanocobalamin injection vials with glass particles that could cause injury during medical use. Affected lots manufactured in India expire July 2024.
Use caution until it’s fixed
Presence of particulate matter: glass
Contact the company
What happened, in plain English
Zydus Pharmaceuticals is recalling cyanocobalamin injection vials that contain glass particles. This could cause injury if the injection is administered improperly. Read more at govinfonow.com/recall/32602-zydus-cyanocobalamin-injection-recall-glass-particulate-matter-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/32602-zydus-cyanocobalamin-injection-recall-glass-particulate-matter-hazard · Updated September 23, 2026 · FDA enforcement record: FDA #D-0600-2024
Cite this page
“Zydus Cyanocobalamin Injection Recall: Glass Particulate Matter Hazard.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32602-zydus-cyanocobalamin-injection-recall-glass-particulate-matter-hazard. Based on FDA recall #D-0600-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0600-2024%22&limit=1).
Why it’s dangerous
Glass particles in the injection vials could become lodged in tissues during administration, potentially causing injury or infection. The particles may not be visible to the eye but can cause harm when injected.
Who’s affected
Healthcare providers using the recalled vials for medical injections. Patients receiving injections from these vials are at risk of injury.
How to tell if you have this one
Check for vials labeled 'Cyanocobalamin Injection, USP, 1,000mcg/mL, 1 mL Multiple-Dose Vial, Rx Only'. Look for lot numbers L200253, L200281, or L200301 manufactured in India with expiration date 07/31/2024.
- Brand
Zydus Pharmaceuticals- Category
Drug
What to do — step by step
Check Vial Label
Look for lot numbers L200253, L200281, or L200301 on the vial label.
Contact Healthcare Provider
If you have the recalled vial, contact your healthcare provider for guidance on next steps.
Where it went and when
Where it was distributed
Distributed in Tennessee.
FDA distribution: “TN” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Tennessee.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Zydus Pharmaceuticals recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0600-2024 (June 27, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0600-2024 to see it in context.
- Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.